Related Experiment Video
Updated: Mar 7, 2026
14:44
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
Published on: October 20, 2018
27.7K
Priming nanoparticle-guided diagnostics and therapeutics towards human organs-on-chips microphysiological system
Jin-Ha Choi1, Jaewon Lee1, Woojung Shin1
1Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712 USA.
Nano Convergence
|February 14, 2017
Summary
Multi-functional nanoparticles (NPs) show promise in medicine but require better validation models. Human organs-on-chips offer a physiologically relevant platform for testing NP safety and efficacy, accelerating drug development.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Development
Background:
- Multi-functional nanoparticles (NPs) are increasingly used in clinical and biomedical applications.
- Current validation methods using 2D cell cultures or 3D organoids lack sufficient human physiological relevance.
- This limits accurate assessment of NP safety and functionality.
Purpose of the Study:
- To highlight the limitations of current in vitro models for nanoparticle (NP) validation.
- To introduce human organs-on-chips as a superior alternative for NP assessment.
- To propose integrating NPs with organs-on-chips for enhanced drug development and diagnostics.
Main Methods:
- Review of existing literature on nanoparticle applications in medicine.
- Discussion of the limitations of traditional cell culture models.
- Exploration of the capabilities of organs-on-chips microphysiological systems.
Main Results:
- Organs-on-chips recapitulate human organ microenvironments, enabling more accurate validation of NP transport, cytotoxicity, biocompatibility, and therapeutic efficacy.
- These systems provide a mechanically dynamic 3D tissue interface.
- NP-guided diagnostics and nanotherapeutics can be effectively evaluated.
Conclusions:
- Human organs-on-chips represent a significant advancement for validating nanoparticle performance.
- Integration of NPs with organs-on-chips can accelerate the development of novel nanotherapeutics.
- This approach offers a novel pathway for rapid detection of pathophysiological biomarkers.
